View Clinical Trial (Medical Research Study)

Effects of Gastric Bypass on Blood Levels of Duloxetine - NCT00989157-58103(Clinical Trial 353805)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Fargo
State:  
ND
Zip Code: 58103
Conditions: Gastric Bypass
Purpose: This study aims to determine the difference, if any, in the pharmacokinetics of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
Study summary:
Criteria: Inclusion Criteria: - Male or female subjects between the ages of 18 and 60 years. - Subjects must be of good general health by history and physical exam. - Ten experimental subjects 9 to 15 months post bariatric surgery (Roux-en-Y procedure), no BMI requirement. - Ten normal control subjects who have met the inclusion criteria and have not received bariatric surgery and who are matched to the surgery subjects according to body mass index, age and sex. - Women of child bearing potential must be practicing an accepted method of birth control (barrier method or oral contraceptive) and have a negative pregnancy test at baseline. - No contraindications to receiving a single capsule of 60 mg of duloxetine Exclusion Criteria: - Allergy to duloxetine or any of its constituents. - Candidates who are pregnant or nursing - Candidates currently receiving any antidepressant. - Candidates that are determined to be poor metabolizers for CYP2D6 - Subjects who smoke or use any nicotine products - Candidates currently receiving a medication that interacts with duloxetine. - Candidates experiencing clinically significant, unstable neurological, hepatic, renal or cardiovascular disease. - Candidates experiencing or with a history of vomiting or diarrhea associated with bariatric surgery - Candidates currently or with a past history of meeting DSM-IV diagnostic criteria for schizophrenia, schizoaffective disorder, bipolar disorder. - Candidates who have participated in an investigational drug study in past 30 days. - Candidates who meet DSM-IV diagnostic criteria for drug/alcohol abuse or dependency or who have a history of drug/alcohol abuse or dependency.
Study is available at: Neuropsychiatric Research Institute
Fargo, ND 58103
United States

Primary Contact:
Joshua C Johnson, BA
Email: jjohnson@nrifargo.com
Phone: 701-365-4970

Secondary Contact:
Joshua C Johnson, BA
Email: jjohnson@nrifargo.com
Phone: 701-365-4970
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.